Publications and communications of Laurie Henry

Henry, L., Berek, J. S., Diaz, I., Feldberg, D., Mocanu, E., Niederberger, C. C., Ohlander, S., Purandare, N., Rosenwaks, Z., Tulandi, T., Wasson, M., Wilailak, S., & Malhotra, J. (December 2023). FIGO statement: Fertility preservation. International Journal of Gynecology and Obstetrics, 163 (3), 790 - 794. doi:10.1002/ijgo.15187

Collee, J., Brichant, G., Chantraine, F., Nisolle, M., & Henry, L. (2023). Étiologie de la prééclampsie après traitements de procréation médicalement assistée. Revue Médicale de Liège.

Collee, J., NOEL, L., Seidel, L., Chantraine, F., Nisolle, M., & Henry, L. (2023). Impact of Assisted Reproduction Techniques on Adverse Maternal Outcomes and on the Rate of Hospitalization in Maternal Intensive Care. Medicina. doi:10.3390/medicina59112030

GALOPIN, C., Henry, L., Timmermans, M., GASPARD, O., & Nisolle, M. (October 2023). P 0 9.17 | EVALUATION OF THE IMPACT OF VITAMIN D LEVELS IN INTRAUTERINE INSEMINATIONS WITH DONOR SPERM. International Journal of Gynecology and Obstetrics, 163 (S1), 100-512. doi:10.1002/ijgo.15058

Poupart, J., Collee, J., Henry, L., & Malchair, A. (2023). La santé mentale des enfants issus de procréation médicalement assistée. Revue Médicale de Liège.

Valdes-Socin, H. G., parisel, A., GASPARD, O., Perrier d'Hauterive, S., Nicolas, H., Henry, L., & Pétrossians, P. (October 2023). Azoospermie non obstructive : auto-immunité, génétique, histologie testiculaire et résultats d’une prise en charge endocrinienne dans une série prospective de 29 patients. Annales d'Endocrinologie, 84, 617. doi:10.1016/j.ando.2023.07.313

Kaluanga Bwanga, P., TREMBLAY LEMOINE, P. L., Timmermans, M., RAVET, S., Munaut, C., Nisolle, M., & Henry, L. (25 August 2023). The Endometrial Microbiota: Challenges and Prospects. Medicina, 59 (9), 1540. doi:10.3390/medicina59091540

Bindels, J., Squatrito, M., Bernet, L., Nisolle, M., Henry, L., & Munaut, C. (16 August 2023). The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models. Medicina, 59 (8), 1474. doi:10.3390/medicina59081474

Timmermans, M., Nisolle, M., BRICHANT, G., Henry, L., Gillet, E., Kellner, B., & Karampelas, S. (16 May 2023). Impact of Adenomyosis and Endometriosis on Chronic Pelvic Pain after Niche Repair. Journal of Clinical Medicine, 12 (10), 3484. doi:10.3390/jcm12103484

Squatrito, M., Blacher, S., Henry, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (19 October 2022). Comparison of Morphological and Digital-Assisted Analysis for BCL6 Endometrial Expression in Women with Endometriosis. Journal of Clinical Medicine, 11 (20), 6164. doi:10.3390/jcm11206164

Vanden Meerschaut, F., Blockeel, C., Blaiberg, S., Delbaere, A., Delvigne, A., Henry, L., Imbert, R., Lie Fong, S., Van De Vijver, A., Wyns, C., & De Neubourg, D. (2022). Multicentre study on rates and reasons for treatment discontinuation in patients with remaining cryopreserved embryos. Reproductive Biomedicine Online. doi:10.1016/j.rbmo.2022.10.005

Munro, M. G., Balen, A. H., Cho, S., Critchley, H. O. D., Díaz, I., Ferriani, R., Henry, L., Mocanu, E., van der Spuy, Z. M., & FIGO Committee on Menstrual Disorders and Related Health Impacts, A. F. C. O. R. M. E. A. I. (30 September 2022). The FIGO Ovulatory Disorders Classification System†. Human Reproduction, 37 (10), 2446 - 2464. doi:10.1093/humrep/deac180

BOUCHER, A., BRICHANT, G., Gridelet, V., Nisolle, M., RAVET, S., Timmermans, M., & Henry, L. (13 September 2022). Implantation Failure in Endometriosis Patients: Etiopathogenesis. Journal of Clinical Medicine, 11 (18), 5366. doi:10.3390/jcm11185366

Munro, M. G., Balen, A. H., Cho, S., Critchley, H. O. D., Díaz, I., Ferriani, R., Henry, L., Mocanu, E., van der Spuy, Z. M., FIGO Committee on Menstrual Disorders and Related Health Impacts, A. F. C. O. R. M. E. A. I., & Nisolle, M. (Other coll.). (2022). The FIGO ovulatory disorders classification system. International Journal of Gynecology and Obstetrics. doi:10.1002/ijgo.14331

Munro, M. G., Balen, A. H., Cho, S., Critchley, H. O. D., Díaz, I., Ferriani, R., Henry, L., Edgar Mocanu, van der Spuy, Z. M., & FIGO Committee on Menstrual Disorders and Related Health Impacts, A. F. C. O. R. M. E. A. I. (2022). The FIGO Ovulatory Disorders Classification System. Fertility and Sterility. doi:10.1016/j.fertnstert.2022.07.009

Henry, L., Vervier, J., BOUCHER, A., BRICHANT, G., GASPARD, O., LABIED, S., Munaut, C., RAVET, S., & Nisolle, M. (04 August 2022). Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat. Journal of Clinical Medicine, 11 (15), 4559. doi:10.3390/jcm11154559

Brichant, G., Laraki, I., Henry, L., Munaut, C., & Nisolle, M. (2021). New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments. International Journal of Molecular Sciences, 22 (19). doi:10.3390/ijms221910498

Henry, L., LABIED, S., Jouan, C., & Nisolle, M. (2021). Preservation of female fertility: The current therapeutic strategy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. doi:10.1002/ijgo.13698

Mawet, M., Perrier d'Hauterive, S., HENRY, L., Potorac, I., Kridelka, F., Nisolle, M., & Pintiaux, A. (2021). Restoration of Fertility in Patients with Spontaneous Premature Ovarian Insufficiency: New Techniques under the Microscope. Journal of Clinical Medicine, 10 (23). doi:10.3390/jcm10235647

Vervier, J., Jouan, C., Nisolle, M., & HENRY, L. (2021). La cryoconservation d’ovocytes : indications médicales et sociétales. Revue Médicale de Liège, 76 (9), 683-688.

Jacob, C. M., Killeen, S. L., McAuliffe, F. M., Stephenson, J., Hod, M., Diaz Yamal, I., Malhotra, J., Mocanu, E., McIntyre, H. D., Kihara, A. B., Ma, R. C., Divakar, H., Kapur, A., Ferriani, R., Ng, E., HENRY, L., Van Der Spuy, Z., Rosenwaks, Z., & Hanson, M. A. H. (September 2020). Prevention of noncommunicable diseases by interventions in the preconception period: A FIGO position paper for action by healthcare practitioners. International Journal of Gynecology and Obstetrics, 151. doi:10.1002/ijgo.13331

Nisolle, M., Brichant, G., & HENRY, L. (2020). Optimizing the outcomes of ovarian tissue transplantation. Fertility and Sterility, 113 (3), 547-548. doi:10.1016/j.fertnstert.2019.11.022

Fransolet, M., NOEL, L., HENRY, L., LABIED, S., Blacher, S., NISOLLE, M., & Munaut, C. (2019). Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-018-1353-8

Labied, S., Jouan, C., Wenders, F., Ravet, S., Gaspard, O., Thonon, F., Gridelet, V., Henry, L., PERRIER d'HAUTERIVE, S., & Nisolle, M. (2019). Comparison between paraffin and mineral oil covering on early human embryo culture: a prospective randomized study. Systems Biology in Reproductive Medicine, 1-6. doi:10.1080/19396368.2018.1492645

Labye, L., WENDERS, F., Nisolle, M., & HENRY, L. (2019). Impact de la fonction thyroïdienne sur le résultat des inséminations artificielles avec sperme de donneur chez des femmes fertiles. Revue Médicale de Liège.

GASPARD, O., VANDERZWALMEN, P., WIRLEITNER, B., RAVET, S., WENDERS, F., EICHEL, V., MOCKOVA, A., SPITZER, D., JOUAN, C., GRIDELET, V., Martens, H., HENRY, L., ZECH, H., PERRIER d'HAUTERIVE, S., & Nisolle, M. (02 April 2018). Impact of high magnification sperm selection on neonatal outcomes: a retrospective study. Journal of Assisted Reproduction and Genetics, 35 (6), 1113-1121. doi:10.1007/s10815-018-1167-8

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., MASEREEL, M.-C., Foidart, J.-M., Noël, A., Nisolle, M., & Munaut, C. (2016). Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival. Journal of Ovarian Research. doi:10.1186/s13048-016-0216-0

Fransolet, M., Henry, L., LABIED, S., Masereel, M.-C., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor. Journal of Ovarian Research, 8 (1), 14. doi:10.1186/s13048-015-0142-6

Fransolet, M., HENRY, L., LABIED, S., Noël, A., Nisolle, M., & Munaut, C. (2015). In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation. Journal of Assisted Reproduction and Genetics. doi:10.1007/s10815-015-0536-9

Henry, L., LABIED, S., Fransolet, M., Kirschvink, N., Blacher, S., Noël, A., Foidart, J.-M., Nisolle, M., & Munaut, C. (2015). Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice. Reproductive Biology and Endocrinology, 13 (1), 15. doi:10.1186/s12958-015-0015-2

Fransolet, M., Labied, S., Henry, L., Masereel, M.-C., Rozet, E., Kirschvink, N., Nisolle, M., & Munaut, C. (2014). Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine. PLoS ONE, 9 (3), 91073. doi:10.1371/journal.pone.0091073

Henry, L., Labied, S., Chiaradia, F., Munaut, C., & NISOLLE, M. (2014). Cancer et droit à la maternité. Revue Médicale de Liège, 69 (4), 188-193.

Labied, S., Delforge, Y., Munaut, C., Blacher, S., Colige, A., Delcombel, R., HENRY, L., Fransolet, M., JOUAN, C., Perrier d'Hauterive, S., Noël, A., Nisolle, M.* , & Foidart, J.-M.*. (2013). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Transplantation, 95 (3), 426-433. doi:10.1097/TP.0b013e318279965c

Henry, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-10.

Henry, L., Fransolet, M., Labied, S., Blacher, S., Munaut, C., Colige, A., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Does vascular endothelial growth factor improve ovarian tissue recovery after cryopreservation? In Giornale italiano di obstetricia e gynecologia (pp. 34(1):203).

Labied, S., Delforge, Y., Blacher, S., Munaut, C., Signolle, N., Colige, A., Janssen, L., HENRY, L., Perrier d'Hauterive, S., JOUAN, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28 (11), 1009.

HENRY, L., Fransolet, M., LABIED, S., Blacher, S., Munaut, C., Kirschvinck, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Does isoforms 111 and 165 of vascular endothelial growth factor (VEGF111 and 165) improve transplanted ovarian tissue survival? Journal of Assisted Reproduction and Genetics, 28, 1009-1010.

LABIED, S., Delforge, Y., Blacher, S., Munaut, C., Signole, N., Colige, A., Janssen, L., HENRY, L., Fransolet, M., PERRIER d'HAUTERIVE, S., JOUAN, C., Kirschvink, N., Noël, A., NISOLLE, M., & Foidart, J.-M. (2011). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28, 1099.

Henry, L. (July 2016). Improvement of ovarian tissue survival after cryopreservation with anti-apoptotic drugs supplementation of transport and freezing media [Paper presentation]. 32ème Congrès annuel de l’European Society of Human Reproduction and Embryology (ESHRE), Helsinki, Finland.